Diabetes
Recent diabetes, obesity drug shortages reveal challenges for prescribers
Recent shortages of the type 2 diabetes therapies semaglutide and tirzepatide, widely reported in the consumer press, appear to be resolving, according to manufacturers and prescribers.
AI identifies reasons for statin nonuse in patients with diabetes at a single center
A deep learning model utilized unstructured electronic health record data to identify specific patient-, physician- and system-level reasons for statin nonuse among patients with diabetes, researchers reported.
Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.
Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.
Use age alone for equitable diabetes screening, researchers say
Making screening decisions for diabetes based on age rather than weight is more equitable and could improve low screening rates, according to research published in the American Journal of Preventive Medicine.
When health plans are detrimental to diabetes care
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Donna Ryan, RN, RDN, MPH, CDCES, FADCES, about changes to standard practices of health plans that could improve diabetes care and health of people with diabetes.
High mortality rates prove lean patients with NAFLD should ‘be taken seriously’
Lean patients with nonalcoholic fatty liver disease had significantly higher mortality than non-lean patients, despite having lower rates of cirrhosis and diabetes, according to research in Alimentary Pharmacology & Therapeutics.
Incorporating psychosocial screening into practice crucial for diabetes clinics
Analyzing psychosocial health and patient-reported outcomes is necessary when treating people with diabetes, and practices should incorporate screening into routine care, according to a review article published in Current Diabetes Reports.
CGM metrics may be better for determining diabetes intervention efficacy than HbA1c
Change in mean glucose may be a better metric for measuring the efficacy of diabetes interventions than HbA1c, time in range and time above range, according to a speaker.
Rise in gestational diabetes linked to changes in screening procedures
An increase in the incidence of gestational diabetes in Canada was primarily explained by changes in screening methods as opposed to changes in population factors, including older maternal age, according to researchers.